HRT Financial’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-81,112
| Closed | -$445K | – | 3331 |
|
|
2025
Q1 | $445K | Buy |
81,112
+60,440
| +292% | +$332K | ﹤0.01% | 1344 |
|
|
2024
Q4 | $70K | Buy |
+20,672
| New | +$70K | ﹤0.01% | 1867 |
|
|
2024
Q2 | – | Sell |
-182,324
| Closed | -$402K | – | 3041 |
|
|
2024
Q1 | $402K | Buy |
182,324
+94,990
| +109% | +$209K | ﹤0.01% | 1305 |
|
|
2023
Q4 | $205K | Buy |
+87,334
| New | +$205K | ﹤0.01% | 1621 |
|
|
2021
Q4 | – | Sell |
-10,435
| Closed | -$25K | – | 3869 |
|
|
2021
Q3 | $25K | Sell |
10,435
-80,080
| -88% | -$192K | ﹤0.01% | 2858 |
|
|
2021
Q2 | $368K | Buy |
+90,515
| New | +$368K | ﹤0.01% | 1921 |
|